The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575
Kaufman, R. J. (1999) · Genes & Development · doi:10.1101/gad.13.10.1211 · Cited by 2,248
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Strategies of antioxidant defense
SIES, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18025.x · Cited by 1,976
Yakes, F. M., & Van Houten, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.514 · Cited by 1,854
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Four deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,587
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Toxic Proteins in Neurodegenerative Disease
Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002) · Science · doi:10.1126/science.1067122 · Cited by 1,251
Caspase Family Proteases and Apoptosis
Fan, T.-J., Han, L.-H., Cong, R.-S., & Liang, J. (2005) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2005.00108.x · Cited by 1,246
Protein regulation by monoubiquitin
Hicke, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056583 · Cited by 1,211
Neurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M., & Bricaire, F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases
Linnane, A., Ozawa, T., Marzuki, S., & Tanaka, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92145-4 · Cited by 983
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Raivich, G., Bohatschek, M., Kloss, C. U. A., Werner, A., Jones, L. L., & Kreutzberg, G. W. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00007-7 · Cited by 844
Gilgun-Sherki, Y., Melamed, E., & Offen, D. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00019-3 · Cited by 838
Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., & Lansbury, P. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01012-7 · Cited by 785
The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains
Walker, J. E. (1992) · Quarterly Reviews of Biophysics · doi:10.1017/s003358350000425x · Cited by 781
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 753
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751
Kessler, M., Terramani, T., Lynch, G., & Baudry, M. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb01881.x · Cited by 739
Poderoso, J. J., Carreras, M. C., Lisdero, C., Riobó, N., Schöpfer, F., & Boveris, A. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0146 · Cited by 726 · cited 1×
“In this way, NO inhibits electron transfer to O2 and increases the rate of production of O2 − and H2O2 [32].”
BackgroundThe Role of Excitotoxicity in Neurodegenerative Disease
Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723
Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M. S., Wu, J. F., & Floyd, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3633 · Cited by 723
Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease
FADEEL, B., & ORRENIUS, S. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01570.x · Cited by 698
Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview
Mariani, E., Polidori, M. C., Cherubini, A., & Mecocci, P. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.04.023 · Cited by 680
HEYES, M. P., SAITO, K., CROWLEY, J. S., DAVIS, L. E., DEMITRACK, M. A., DER, M., DILLING, L. A., ELIA, J., KRUESI, M. J. P., LACKNER, A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 680
Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R., & Pellicciari, R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease
Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531
Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
Saigoh, K., Wang, Y.-L., Suh, J.-G., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T., et al. (1999) · Nature Genetics · doi:10.1038/12647 · Cited by 502
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
Electron transport chain defects in Alzheimer's disease brain
Parker, W. D., BA, J. P., Filley, C. M., & Kleinschmidt-DeMasters, B. K. (1994) · Neurology · doi:10.1212/wnl.44.6.1090 · Cited by 494
Bolaños, J. P., Heales, S. J. R., Land, J. M., & Clark, J. B. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64051965.x · Cited by 492
Nitric oxide, mitochondria and neurological disease
Heales, S. J. R., Bolaños, J. P., Stewart, V. C., Brookes, P. S., Land, J. M., & Clark, J. B. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00168-6 · Cited by 476
Selective degradation of oxidatively modified protein substrates by the proteasome
Grune, T., Merker, K., Sandig, G., & Davies, K. J. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00809-x · Cited by 475
The molecular bases of Alzheimer’s disease and other neurodegenerative disorders
Maccioni, R. B., Muñoz, J. P., & Barbeito, L. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00316-2 · Cited by 474
Energetics in the pathogenesis of neurodegenerative diseases
Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 474
II. Excitotoxic models for neurodegenerative disorders
Schwarcz, R., Foster, A. C., French, E. D., Whetsell, W. O., & Köhler, C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90148-6 · Cited by 466
Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling
Hong, S. J., Dawson, T. M., & Dawson, V. L. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.005 · Cited by 463
Role of mitochondrial DNA in toxic responses to oxidative stress
Van Houten, B., Woshner, V., & Santos, J. H. (2006) · DNA Repair · doi:10.1016/j.dnarep.2005.03.002 · Cited by 454
Mitochondrial nitric oxide synthase
GHAFOURIFAR, P., & CADENAS, E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.005 · Cited by 428
Drug delivery to mitochondria: the key to mitochondrial medicine
Murphy, M. P., & Smith, R. A. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00069-1 · Cited by 426
Mitochondria, free radicals, and neurodegeneration
Beal, M. F. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80100-0 · Cited by 424
Almeida, A., Almeida, J., Bolaños, J. P., & Moncada, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261560998 · Cited by 423
Replicating Huntington's disease phenotype in experimental animals
Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00024-x · Cited by 395
Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites
Moroni, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00196-x · Cited by 346
Lu, F., Selak, M., O’Connor, J., Croul, S., Lorenzana, C., Butunoi, C., & Kalman, B. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00343-9 · Cited by 331
Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus
Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 330
Tavares, R. G., Tasca, C. I., Santos, C. E. S., Alves, L. B., Porciúncula, L. O., Emanuelli, T., & Souza, D. O. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00133-4 · Cited by 320
Birch, P. J., Grossman, C. J., & Hayes, A. G. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90367-6 · Cited by 318
Mitochondrial intermembrane junctional complexes and their role in cell death
Crompton, M. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00011.x · Cited by 317
Kynurenine pathway abnormalities in Parkinson's disease
Ogawa, T., Matson, W. R., Beal, M. F., Myers, R. H., Bird, E. D., Milbury, P., & Saso, S. (1992) · Neurology · doi:10.1212/wnl.42.9.1702 · Cited by 315
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
Stoy, N., Mackay, G. M., Forrest, C. M., Christofides, J., Egerton, M., Stone, T. W., & Darlington, L. G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03070.x · Cited by 310
An inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309
Kynurenines in the CNS: from endogenous obscurity to therapeutic importance
Stone, T. W. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00032-0 · Cited by 306
Quinolinic acid and other kynurenines in the central nervous system
Stone, T. W., & Connick, J. H. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90063-6 · Cited by 304
Organic ion transport during seven decades the amino acids
Christensen, H. N. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(84)90012-1 · Cited by 287
Mitochondria and degenerative disorders
Orth, M., & Schapira, A. H. V. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1425 · Cited by 280
Presence of Kynurenic Acid in the Mammalian Brain
Moroni, F., Russi, P., Lombardi, G., Beni, M., & Carlà, V. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04852.x · Cited by 278
Quinolinic acid is a potent lipid peroxidant in rat brain homogenates
Rios, C., & Santamaria, A. (1991) · Neurochemical Research · doi:10.1007/bf00966592 · Cited by 271
Papa, S. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00077-1 · Cited by 266
The kynurenine pathway of tryptophan degradation as a drug target
Schwarcz, R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.006 · Cited by 265
Swartz, K., During, M., Freese, A., & Beal, M. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02965.1990 · Cited by 258
Presynaptic kynurenate‐sensitive receptors inhibit glutamate release
Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., & Moroni, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01592.x · Cited by 254
Endoplasmic reticulum stress response and neurodegeneration
Paschen, W., & Mengesdorf, T. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.019 · Cited by 252
Ubiquitin–proteasome system and Parkinson's diseases
Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.021 · Cited by 245
Mitochondrial respiratory chain and free radical generation in stroke
Moro, M. A., Almeida, A., Bolaños, J. P., & Lizasoain, I. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.07.010 · Cited by 240
Kynurenine metabolism in Alzheimer's disease
Baran, H., Jellinger, K., & Deecke, L. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050149 · Cited by 236
DNA DEGRADATION IN DEVELOPMENT AND PROGRAMMED CELL DEATH
Nagata, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115811 · Cited by 230
Identification and quantification of kynurenic acid in human brain tissue
Turski, W. A., Nakamura, M., Todd, W. P., Carpenter, B. K., Whetsell, W. O., & Schwarcz, R. (1988) · Brain Research · doi:10.1016/0006-8993(88)90815-3 · Cited by 219
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex
Flint Beal, M., Matson, W. R., Storey, E., Milbury, P., Ryan, E. A., Ogawa, T., & Bird, E. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90191-m · Cited by 218
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease
Guillemin, G. J., & Brew, B. J. (2002) · Redox Report · doi:10.1179/135100002125000550 · Cited by 212
Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover
Sullivan, P. G., Dragicevic, N. B., Deng, J.-H., Bai, Y., Dimayuga, E., Ding, Q., Chen, Q., Bruce-Keller, A. J., & Keller, J. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313579200 · Cited by 202
Parsons, C. G., Danysz, W., Quack, G., Hartmann, S., Lorenz, B., Wollenburg, C., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37160-5 · Cited by 198
β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria
Canevari, L., Clark, J. B., & Bates, T. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01028-5 · Cited by 196
Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration
Stewart, V. C., & Heales, S. J. R. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01327-8 · Cited by 190
Mitochondrial bioenergetics in aging
Lenaz, G., D’Aurelio, M., Merlo Pich, M., Genova, M. L., Ventura, B., Bovina, C., Formiggini, G., & Parenti Castelli, G. (2000) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(00)00177-8 · Cited by 189
Anderton, B. H. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00426-2 · Cited by 187
Neurodegenerative disorders of protein aggregation
Shastry, B. S. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(02)00196-1 · Cited by 186
Role of nitric oxide in Parkinson's disease
Zhang, L., Dawson, V. L., & Dawson, T. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.007 · Cited by 184
Marchetti, B., & Abbracchio, M. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.007 · Cited by 175
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
Rassoulpour, A., Wu, H., Ferrė, S., & Schwarcz, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03134.x · Cited by 174
Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.
Ganong, A. H., & Cotman, C. W. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38782-3 · Cited by 172
Mitochondria, Ca2+ and neurodegenerative disease
Krieger, C., & Duchen, M. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01842-3 · Cited by 171
Role of Kynurenines in the Central and Peripherial Nervous Systems
Nemeth, H., Toldi, J., & Vecsei, L. (2005) · Current Neurovascular Research · doi:10.2174/1567202054368326 · Cited by 169 · cited 1×
“In some neurodegenerative diseases or other pathological states, the changes in the KYN pathway metabolites are modest and balanced with regard to the two KYN branches, probably depending on whether astrocytes or microglia cells are preferentially taking part in the process (reviewed by [101,102,124,125]).”
BackgroundSelf-citationAging and molecular chaperones
Soti, C. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00185-2 · Cited by 167
Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease
Carreras, M. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.02.014 · Cited by 167
Two kynurenine aminotransferases in human brain
Okuno, E., Nakamura, M., & Schwarcz, R. (1991) · Brain Research · doi:10.1016/0006-8993(91)91583-m · Cited by 166
Kynurenic acid has a dual action on AMPA receptor responses
Prescott, C., Weeks, A. M., Staley, K. J., & Partin, K. M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.051 · Cited by 164
Tryptophan Metabolites and Brain Disorders
Stone, T. W., Mackay, G. M., Forrest, C. M., Clark, C. J., & Darlington, L. G. (2003) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2003.129 · Cited by 161
Virag, L. (2005) · Current Vascular Pharmacology · doi:10.2174/1570161054368625 · Cited by 160
Protein quality control in Alzheimer's disease by the ubiquitin proteasome system
de Vrij, F. M. S., Fischer, D. F., VANLEEUWEN, F., & Hol, E. M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.001 · Cited by 155
Quinolinic acid induces oxidative stress in rat brain synaptosomes
Santamaría, A., Galván‐Arzate, S., Lisý, V., Ali, S. F., Duhart, H. M., Osorio‐Rico, L., Ríos, C., & Sut'astný, F. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00049 · Cited by 152
Endogenous neurotoxins from tryptophan
Stone, T. W. (2001) · Toxicon · doi:10.1016/s0041-0101(00)00156-2 · Cited by 147
de Carvalho, L. P., Bochet, P., & Rossier, J. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00091-7 · Cited by 144
Miranda, A., Boegman, R. J., Beninger, R. J., & Jhamandas, K. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00655-0 · Cited by 139
Sapko, M. T., Guidetti, P., Yü, P., Tagle, D. A., Pellicciari, R., & Schwarcz, R. M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.004 · Cited by 133
Modulation of the Mitochondrial Permeability Transition by Nitric Oxide
Balakirev, M. Y., Khramtsov, V. V., & Zimmer, G. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00710.x · Cited by 127
Jauch, D., Urbańska, E. M., Guidetti, P., Bird, E. D., Vonsattel, J., Whetsell, W. O., & Schwarcz, R. M. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00280-2 · Cited by 127
Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages
Chiarugi, A., Calvani, M., Meli, E., Traggiai, E., & Moroni, F. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00418-0 · Cited by 125
Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum
Rodríguez-Martínez, E., Camacho‐Morales, A., Maldonado, P. D., Pedraza‐Chaverrí, J., Santamarı́a, D., Galván‐Arzate, S., & Santamaría, A. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02474-9 · Cited by 124
Kita, T., Morrison, P. F., Heyes, M. P., & Markey, S. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00955.x · Cited by 123
Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus
Du, F., Schmidt, W., Okuno, E., Kido, R., Köhler, C., & Schwarcz, R. M. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903210313 · Cited by 122
Kynurenate production by cultured human astrocytes
Kiss, C., Ceresoli‐Borroni, G., Guidetti, P., Zielke, C. L., Zielke, H. R., & Schwarcz, R. M. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0770-z · Cited by 121
Vécsei, L., Miller, J. M., Macgarvey, U., & Beal, M. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90184-y · Cited by 118
Self-citationDavey, G. P., Canevari, L., & Clark, J. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062564.x · Cited by 117
Foster, A. C., Miller, L. P., Oldendorf, W. H., & Schwarcz, R. M. (1984) · Experimental Neurology · doi:10.1016/0014-4886(84)90239-5 · Cited by 116
Shear, D. A., Dong, J., Gundy, C. D., Haik-Creguer, K. L., & Dunbar, G. L. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00070-0 · Cited by 116
Moroni, F., Russi, P., Carlà, V., & Lombardi, G. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90285-6 · Cited by 113
Brain Quinolinic Acid in Huntington's Disease
Reynolds, G. P., Pearson, S. J., Halket, J. M., & Sandier, M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02503.x · Cited by 109
Guillemin, G. J., Smith, D. G., Kerr, S. J., Smythe, G. A., Kapoor, V., Armati, P. J., & Brew, B. J. (2000) · Redox Report · doi:10.1179/135100000101535375 · Cited by 108
The Modulation of Mitochondrial Nitric-oxide Synthase Activity in Rat Brain Development
Galdo, N. A. R., Melani, M., Sanjuan, N. A., Fiszman, M. L., Gravielle, M. C., Carreras, M. C., Cadenas, E., & Poderoso, J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204580200 · Cited by 104
Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia
Schwarcz, R. M., Tamminga, C. A., Kurlan, R., & Shoulson, I. (1988) · Annals of Neurology · doi:10.1002/ana.410240417 · Cited by 102
Nakao, N., & Brundin, P. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00223-0 · Cited by 96
Guidetti, P., Eastman, C. L., & Schwarcz, R. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062621.x · Cited by 94
Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo
Perkins, M. N., & Stone, T. W. (1985) · Experimental Neurology · doi:10.1016/0014-4886(85)90072-x · Cited by 94
Implications of Protein Degradation in Aging
Goto, S., Takahashi, R., Kumiyama, A., Radak, Z. O., Hayashi, T., Takenouchi, M., & Abe, R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05635.x · Cited by 88
Degeneration of neuronal cells due to oxidative stress—microglial contribution
Koutsilieri, E., Scheller, C., Tribl, F., & Riederer, P. F. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00021-4 · Cited by 86
Free radicals and neurodegeneration
Cadet, J. L. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90102-3 · Cited by 85
Baran, H., Cairns, N. J., Lubec, B., & Lübec, G. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00173-7 · Cited by 83
Age-related structural and functional changes of brain mitochondria
Toescu, E. C., Myronova, N., & Verkhratsky, A. (2000) · Cell Calcium · doi:10.1054/ceca.2000.0167 · Cited by 82
Possible participation of superoxide anion in the intestinal tryptophan 2,3-dioxygenase reaction.
Hirata, F., & Hayaishi, O. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45852-3 · Cited by 81
Wu, H., Guidetti, P., Goodman, J. H., Varasi, M., Ceresoli‐Borroni, G., Speciale, C., Scharfman, H. E., & Schwarcz, R. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00030-0 · Cited by 80
Kynurenic acid antagonists and kynurenine pathway inhibitors
Stone, T. W. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.633 · Cited by 79
Degradation of Tryptophan in Neurodegenerative Disorders
Widner, B., Leblhuber, F., Walli, J., Tilz, G. P., Demel, U., & Fuchs, D. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_19 · Cited by 74
Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatum
Davies, S. W., & Roberts, P. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90156-x · Cited by 67
INCREASED BRAIN 3-HYDROXYKYNURENINE IN HUNTINGTON'S DISEASE
Reynolds, G. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90987-2 · Cited by 66
Shear, D. A., Dong, J., Haik-Creguer, K. L., Bazzett, T. J., Albin, R. L., & Dunbar, G. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6767 · Cited by 61
Knyihár‐Csillik, E., Csillik, B., Pákáski, M., Krisztin‐Péva, B., Dobó, E., Okuno, E., & Vécsei, L. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.043 · Cited by 61
Self-citationLuchowski, P., Luchowska, E., Turski, W. A., & Urbańska, E. M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00735-8 · Cited by 59
Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture
Kikuchi, S., & Kim, S. U. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490360508 · Cited by 58
The aggravating role of the ubiquitin–proteasome system in neurodegeneration
Ardley, H. C., Hung, C.-C., & Robinson, P. A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.058 · Cited by 55
Pöeggeler, B., Rassoulpour, A., Guidetti, P., et al. (1998) · Developmental Neuroscience · doi:10.1159/000017309 · Cited by 54
Németh, H., Robotka, H., Kis, Z., Rózsa, É., Janáky, T., Somlai, C., Marosi, M., Farkas, T., Toldi, J., & Vécsei, L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.007 · Cited by 53
Self-citationMitochondrial encephalomyopathies: what next?
DiMauro, S. (1996) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799110 · Cited by 50
Ross, C. A., & Margolis, R. L. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00014-1 · Cited by 48
Effects of Antimycin A and 2-Deoxyglucose on Energy Metabolism in Washed Human Platelets
Holmsen, H., & Robkin, L. (1979) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657047 · Cited by 48
Nakao, N., Ogura, M., Nakai, K., & Itakura, T. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01806.1998 · Cited by 46
Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord
Kapoor, R., Okuno, E., Kido, R., et al. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00039 · Cited by 46
Nakai, M., Qin, Z., Wang, Y., & Chase, T. N. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00310-6 · Cited by 45
Knyihár‐Csillik, E., Okuno, E., & Vécsei, L. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00306-1 · Cited by 42
Self-citationSantamaría, D., Espinoza-González, V., Rı́os, C., & Santamarı́a, A. (1999) · Neurochemical Research · doi:10.1023/a:1020949812581 · Cited by 37
Jauch, D., Sethy, V. H., Weick, B. G., et al. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90171-x · Cited by 34
Vécsei, L., & Beal, M. F. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90123-h · Cited by 33
Self-citationSteele, R. J., & Stewart, M. G. (1993) · Behavioral and Neural Biology · doi:10.1016/0163-1047(93)90145-8 · Cited by 31
Robotka, H., Németh, H., Somlai, C., Vécsei, L., & Toldi, J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.043 · Cited by 30
Self-citationBordelon, Y. M., & Chesselet, M. ‐. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00239-0 · Cited by 29
Modulation and Function of Kynurenic Acid in the Immature Rat Brain
Schwarcz, R. M., Ceresoli‐Borroni, G., Wu, H., Rassoulpour, A., Pöeggeler, B., Hodgkins, P., & Guidetti, P. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_17 · Cited by 21
Sas, K., Csete, K., V??csei, L., & Papp, J. G. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200309000-00012 · Cited by 19
Self-citationLuchowska, E., Luchowski, P., Wielosz, M., Turski, W. A., & Urbańska, E. M. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1459 · Cited by 15
Neocortical neuron number in humans: Effect of sex and age
(1997) · doi:10.1002/(sici)1096-9861(19970728)384:2<312::aid-cne10>3.0.co;2-k
Cited by
Review on in vivo and in vitro methods evaluation of antioxidant activity
Alam, M. N., Bristi, N. J., & Rafiquzzaman, M. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.05.002 · Cited by 1,758
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
Guo, C., Sun, L., Chen, X., & Zhang, D. (2013) · PubMed · doi:10.3969/j.issn.1673-5374.2013.21.009 · Cited by 1,298
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders
Islam, M. T. (2017) · Neurological Research · doi:10.1080/01616412.2016.1251711 · Cited by 983
Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Bhat, A. H., Dar, K. B., Anees, S., Zargar, M. A., Masood, A., Sofi, M. A., & Ganie, S. A. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.025 · Cited by 928
Flieger, J., Flieger, W., Baj, J., & Maciejewski, R. (2021) · Materials · doi:10.3390/ma14154135 · Cited by 441
Metadata
- Authors
- Sas, K., Robotka, H., Toldi, J., & Vécsei, L.
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 257
- Issue
- 1-2
- Pages
- 221-239
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W2153528954
- Cited by
- 463
- References
- 170
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.